Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
This 12-minute conference talk from the Cancer Genomics Consortium (CGC) 2024 Annual Meeting presents recommendations for best practices in testing and reporting fluorescence in situ hybridization (FISH) studies in multiple myeloma. Delivered by Xinyan Lu, the presentation outlines guidelines developed by the CGC working group to standardize and improve the accuracy of genomic testing for multiple myeloma patients. Learn about the latest approaches that help ensure cancer patients receive accurate diagnoses of their underlying genomic alterations, ultimately supporting more appropriate therapeutic decisions. The CGC represents clinical cytogeneticists, molecular geneticists, and molecular pathologists dedicated to education and promoting excellence in clinical cancer genomics, with the vision that all cancer patients benefit from precise genomic testing.
